Filing Details
- Accession Number:
- 0000791908-14-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-20 15:38:32
- Reporting Period:
- 2014-03-18
- Filing Date:
- 2014-03-20
- Accepted Time:
- 2014-03-20 15:38:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
791908 | Xoma Corp | XOMA | Pharmaceutical Preparations (2834) | 942756657 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1210905 | D Paul Rubin | C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710 | Sr. Vp Clinical Dev. & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2014-03-18 | 12,142 | $0.00 | 84,163 | No | 4 | M | Direct | |
Common Shares | Disposition | 2014-03-18 | 4,661 | $6.32 | 79,502 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2014-03-18 | 18,205 | $0.00 | 97,707 | No | 4 | M | Direct | |
Common Shares | Disposition | 2014-03-18 | 6,988 | $6.32 | 90,719 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2014-03-18 | 6,000 | $3.04 | 96,719 | No | 4 | M | Direct | |
Common Shares | Disposition | 2014-03-18 | 6,000 | $6.31 | 90,719 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Incentive Share Option (right to buy) | Disposition | 2014-03-18 | 6,000 | $3.04 | 6,000 | $3.04 |
Common Shares | Restricted Stock Units | Disposition | 2014-03-18 | 12,142 | $0.00 | 12,142 | $0.00 |
Common Shares | Restricted Stock Units | Disposition | 2014-03-18 | 18,205 | $0.00 | 18,205 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
92,040 | 2021-05-31 | No | 4 | M | Direct | |
24,282 | 2014-03-18 | 2016-03-18 | No | 4 | M | Direct |
18,205 | 2014-03-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 5,310 | Indirect | by 401(k) |
Footnotes
- These restricted stock units were granted on February 28, 2013 and are scheduled to vest in substantially equal installments on each of March 18, 2014, March 18, 2015, and March 18, 2016.
- Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This nondiscretionary transaction represents the settlement of vested restricted stock units in shares of common stock.
- Shares sold on the open market to satisfy the minimum amount of taxes required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's equity incentive plan.
- These restricted stock units are scheduled to vest in substantially equal installments annually over three years, with the first installment vesting on March 18, 2013.
- This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.
- This transaction was executed in multiple trades ranging at prices from $6.16 to $6.41.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
- Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to (a) 25% of the option shares upon the first anniversary of the date of grant, and (b) the remaining 75% of the option shares in thirty-six (36) equal and consecutive monthly installments beginning one year and one month after the date of grant.